Use of Extrusion - Enabled Pharmaceutical Processes in Drug Development
via a Streamlined Regulatory Pathway

Free Seminar

Date: Thursday, August 27, 2015
Time: 9:00 a.m. - 12:00 p.m.
Location: North Carolina Biotechnology Center
Congress Room
15 TW Alexander Drive
Research Triangle Park, NC











Join us for a free half-day educational seminar on combining extrusion-enabled pharmaceutical development with a streamlined regulatory strategy based on the 505(b)(2) NDA pathway to achieve superior product quality attributes and facilitate the drug development and registration process flow. You will learn

  • The elements of drug development strategies incorporating extrusion-enabled processes and streamlined regulatory strategies
  • How extrusion-based pharmaceutical development helps enable continuous product manufacturing that is more efficient than traditional batch manufacturing
  • How to enhance bioavailability of poorly soluble APIs, generate new intellectual property and gain productivity by switching to continuous wet granulation processes
  • How the 505(b)(2) regulatory pathway facilitates time and cost efficiency of drug development without compromising patient safety
  • Illustrative examples of extrusion enabled processes and streamlined regulatory requirements in approved products

Seating is limited, so register today using the form on the right to reserve your space!